The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Sustained Reduction in Severe Hypoglycemia in Adults With Type 1 Diabetes Complicated by Impaired Awareness of Hypoglycemia: Two-Year Follow-up in the HypoCOMPaSS Randomized Clinical Trial
Open accessAbstract
OBJECTIVE: Severe hypoglycemia is a feared complication of type 1 diabetes; yet, few trials have targeted prevention using optimized self-management (educational, therapeutic, and technological support). We aimed to investigate whether improved awareness and reduced severe hypoglycemia, achieved during an intensive randomized clinical trial (RCT), were sustained after return to routine care. RESEARCH DESIGN AND METHODS: Ninety-six adults with type 1 diabetes (29 ± 12 years’ duration) and impaired awareness of hypoglycemia at five U.K. tertiary referral diabetes centers were recruited into a 24-week 2 × 2 factorial RCT (HypoCOMPaSS). Participants were randomized to pump (continuous subcutaneous insulin infusion [CSII]) or multiple daily injections (MDIs) and real-time continuous glucose monitoring (RT-CGM) or self-monitoring of blood glucose (SMBG), with equal education/attention to all groups. At 24 weeks, participants returned to routine care with follow-up until 24 months, including free choice of MDI/CSII; RT-CGM vs. SMBG comparison continued to 24 months. Primary outcome was mean difference (baseline to 24 months [between groups]) in hypoglycemia awareness. RESULTS: Improvement in hypoglycemia awareness was sustained (Gold score at baseline 5.1 ± 1.1 vs. 24 months 3.7 ± 1.9; P < 0.0001). Severe hypoglycemia rate was reduced from 8.9 ± 12.8 episodes/person-year over the 12 months prestudy to 0.4 ± 0.8 over 24 months (P < 0.0001). HbA1c improved (baseline 8.2 ± 3.2% [66 ± 12 mmol/mol] vs. 24 months 7.7 ± 3.1% [61 ± 10 mmol/mol]; P = 0.003). Improvement in treatment satisfaction and reduced fear of hypoglycemia were sustained. There were no significant differences between interventions at 24 months. CONCLUSIONS: Optimized insulin replacement and glucose monitoring underpinned by hypoglycemia-focused structured education should be provided to all with type 1 diabetes complicated by impaired awareness of hypoglycemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several evidence-based training programs have been developed for this purpose and have been demonstrated to reduce rates of hypoglycemia and improve quality of life among people with type 1 diabetes and impaired hypoglycemia awareness (74,155,156).”
From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [156]
In the citing paper
“Structured education programs, such as Dose Adjustment For Normal Eating (DAFNE) and blood glucose awareness training (BGAT), which provide informed support for active insulin dose self-adjustment, are the key to the prevention of hypoglycemia and lead to sustained falls in level 3 hypoglycemia rates in those at high risk (122,123).”
Citations
Cites
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R. (2013) · Diabetes Care · doi:10.2337/dc12-2480 · Cited by 1,389
Self-citationBolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893
Risk of hypoglycaemia in types 1 and 2 diabetes: Effects of treatment modalities and their duration
UK Hypoglycaemia Study Group (2007) · Diabetologia · doi:10.1007/s00125-007-0599-y · Cited by 825
Gold, A. E., Macleod, K. M., & Frier, B. M. (1994) · Diabetes Care · doi:10.2337/diacare.17.7.697 · Cited by 810
Handbook of Psychology and Diabetes
(2013) · Routledge eBooks · doi:10.4324/9781315077369 · Cited by 661
Threshold-based insulin-pump interruption for reduction of hypoglycemia
Bergenstal, R. M., Klonoff, D. C., Garg, S. K., Bode, B. W., Meredith, M., Slover, R. H., Ahmann, A. J., Welsh, J. B., Lee, S. W., & Kaufman, F. R. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303576 · Cited by 652
Clarke, W. L., Cox, D. J., Gonder-Frederick, L. A., Julian, D., Schlundt, D., & Polonsky, W. (1995) · Diabetes Care · doi:10.2337/diacare.18.4.517 · Cited by 651
Pickup, J. C., & Sutton, A. J. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02486.x · Cited by 617
International Hypoglycaemia Study Group (2017) · Diabetes Care · doi:10.2337/dc16-2215 · Cited by 608
Ly, T. T., Nicholas, J. A., Retterath, A., Lim, E. M., Davis, E. A., & Jones, T. W. (2013) · JAMA · doi:10.1001/jama.2013.277818 · Cited by 411 · cited 1×
“has not been reported in other trials of RT-CGM (with [7,8] or without [29] LGS), possibly because a psycho-educational”
MethodPrevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes
Geddes, J., Schopman, J. E., Zammitt, N. N., & Frier, B. M. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02413.x · Cited by 387
van Beers, C. A. J., DeVries, J. H., Kleijer, S. J., Smits, M. M., Geelhoed-Duijvestijn, P. H., Kramer, M. H. H., Diamant, M., Snoek, F. J., & Serné, E. H. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30193-0 · Cited by 386
The International Hypoglycaemia Study Group (2017) · Diabetologia · doi:10.1007/s00125-016-4146-6 · Cited by 360
Symptomatic Hypoglycaemia in 411 Type 1 Diabetic Patients
Pramming, S., Thorsteinsson, B., Bendtson, I., & Binder, C. (1991) · Diabetic Medicine · doi:10.1111/j.1464-5491.1991.tb01575.x · Cited by 337
Psychometric properties of the hypoglycemia fear survey-ii for adults with type 1 diabetes
Gonder-Frederick, L. A., Schmidt, K. M., Vajda, K. A., Greear, M. L., Singh, H., Shepard, J. A., & Cox, D. J. (2011) · Diabetes Care · doi:10.2337/dc10-1343 · Cited by 337
Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry
Wong, J. C., Foster, N. C., Maahs, D. M., Raghinaru, D., Bergenstal, R. M., Ahmann, A. J., Peters, A. L., Bode, B. W., Aleppo, G., Hirsch, I. B., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0303 · Cited by 318
Hopkins, D., Lawrence, I., Mansell, P., Thompson, G., Amiel, S., Campbell, M., & Heller, S. (2012) · Diabetes Care · doi:10.2337/dc11-1579 · Cited by 265
Self-citationReddy, M., Jugnee, N., El Laboudi, A., Spanudakis, E., Anantharaja, S., & Oliver, N. (2018) · Diabetic Medicine · doi:10.1111/dme.13561 · Cited by 245
Recall of severe hypoglycaemia and self‐estimated state of awareness in type 1 diabetes
Pedersen‐Bjergaard, U., Pramming, S., & Thorsteinsson, B. (2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.377 · Cited by 240
Little, S. A., Leelarathna, L., Walkinshaw, E., Tan, H. K., Chapple, O., Lubina-Solomon, A., Chadwick, T. J., Barendse, S., Stocken, D. D., Brennand, C., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0030 · Cited by 237
Self-citationBlood Glucose Awareness Training (BGAT-2)
Cox, D. J., Gonder-Frederick, L., Polonsky, W., Schlundt, D., Kovatchev, B., & Clarke, W. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.637 · Cited by 235
Insulin Pump Therapy With Automated Insulin Suspension in Response to Hypoglycemia
Choudhary, P., Shin, J., Wang, Y., Evans, M. L., Hammond, P. J., Kerr, D., Shaw, J. A. M., Pickup, J. C., & Amiel, S. A. (2011) · Diabetes Care · doi:10.2337/dc10-2411 · Cited by 175
Self-citationcontinuous Subcutaneous Insulin Infusion in the Treatment of Diabetes Mellitus
Pickup, J. C., Keen, H., Viberti, G. C., White, M. C., Kohner, E. M., Parsons, J. A., & Alerti, K. G. M. M. (1980) · Diabetes Care · doi:10.2337/diacare.3.2.290 · Cited by 175
Yeoh, E., Choudhary, P., Nwokolo, M., Ayis, S., & Amiel, S. A. (2015) · Diabetes Care · doi:10.2337/dc15-0102 · Cited by 154
Hendrieckx, C., Halliday, J. A., Bowden, J. P., Colman, P. G., Cohen, N. D., Jenkins, A. J., & Speight, J. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.12.005 · Cited by 93
Self-citationCox, D. J., Kovatchev, B., Kovatchev, B., Koev, D., Koeva, L., Dachev, S., Tcharaktchiev, D., Protopopova, A., Gonder-Frederick, L., & Clarke, W. (2004) · International Journal of Behavioral Medicine · doi:10.1207/s15327558ijbm1104_4 · Cited by 88
The Diabetes Treatment Satisfaction Questionnaire
Westaway, M. S., & Seager, J. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.2.618 · Cited by 77
Speight, J., Barendse, S. M., Singh, H., Little, S. A., Inkster, B., Frier, B. M., Heller, S. R., Rutter, M. K., & Shaw, J. A. M. (2016) · Diabetic Medicine · doi:10.1111/dme.12824 · Cited by 76 · cited 1×
“caemia Awareness Questionnaire (HypoAQ) “impaired awareness” subscale score [16]), severe hypoglycemia rate and proportion affected, biochemical hypoglycemia (identified by blinded CGM profile:”
BackgroundSelf-citationA Biopsychobehavioral Model of Risk of Severe Hypoglycemia
Gonder-Frederick, L. A., Cox, D. J., Kovatchev, B. P., Schlundt, D. G., & Clarke, W. L. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.661 · Cited by 76
Rickels, M. R., Peleckis, A. J., DALTON-BAKES, C. V., Naji, J. R., Ran, N. A., Nguyen, H.-L., O’Brien, S., Chen, S., Lee, I., & Schutta, M. H. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01516 · Cited by 63
Hermanns, N., Kulzer, B., Krichbaum, M., Kubiak, T., & Haak, T. (2010) · Diabetes Care · doi:10.2337/dc09-1656 · Cited by 52
Little, S. A., Leelarathna, L., Barendse, S. M., Walkinshaw, E., Tan, H. K., Lubina Solomon, A., de Zoysa, N., Rogers, H., Choudhary, P., Amiel, S. A., et al. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2492 · Cited by 48
Self-citationLittle, S. A., Chadwick, T. J., Choudhary, P., Brennand, C., Stickland, J., Barendse, S., Olateju, T., Leelarathna, L., Walkinshaw, E., Tan, H. K., et al. (2012) · BMC Endocrine Disorders · doi:10.1186/1472-6823-12-33 · Cited by 34
Self-citationPersistence of Continuous Glucose Monitoring Use in a Community Setting 1 Year After Purchase
Chamberlain, J. J., Dopita, D., & Gilgen, E. (2013) · Clinical Diabetes · doi:10.2337/diaclin.31.3.106 · Cited by 24
de Bock, M. I., Cooper, M. N., Retterath, A. J., Nicholas, J. A., Ly, T. T., Jones, T. W., & Davis, E. A. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816633484 · Cited by 23
IN CONTROL of type 1 diabetes, despite hypoglycaemia unawareness
Youssef, J. E. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30261-3 · Cited by 3
Cited by
Holt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetes Care · doi:10.2337/dci21-0043 · Cited by 699
“Structured education programs, such as Dose Adjustment For Normal Eating (DAFNE) and blood glucose awareness training (BGAT), which provide informed support for active insulin dose self-adjustment, are the key to the prevention of hypoglycemia and lead to sustained falls in level 3 hypoglycemia rates in those at high…”
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s006 · Cited by 440
Holt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05568-3 · Cited by 378
Advances in technology for management of type 1 diabetes
Beck, R. W., Bergenstal, R. M., Laffel, L. M., & Pickup, J. C. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31142-0 · Cited by 242
2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
Hur, K. Y., Moon, M. K., Park, J. S., Kim, S.-K., Lee, S.-H., Yun, J.-S., Baek, J. H., Noh, J., Lee, B.-W., Oh, T. J., et al. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0156 · Cited by 226
“In particular, patients with T1DM who develop hypoglycemia unawareness or severe hypoglycemia should receive specialized and professional education to prevent hypoglycemia and restore cognitive abilities in case of hypoglycemia (RCT, Limited) [55].”
Background
Metadata
- Authors
- Little, S. A., Speight, J., Leelarathna, L., Walkinshaw, E., Tan, H. K., Bowes, A., Lubina-Solomon, A., Chadwick, T. J., Stocken, D. D., Brennand, C., Marshall, S. M., Wood, R., Kerr, D., Flanagan, D., Heller, S. R., Evans, M. L., & Shaw, J. A. M.
- Affiliations
- Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
- Deakin University (AU)
- University of Cambridge (GB)
- University of Sheffield (GB)
- Peninsula College of Medicine and Dentistry (GB)
- Bournemouth University (GB)
- Newcastle University (GB)
- Corresponding author
- Shaw, James A.M.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2018-04-16
- Volume
- 41
- Issue
- 8
- Pages
- 1600-1607
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2800556369
- Cited by
- 86
- References
- 38
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 12 · 2023: 9 · 2022: 12 · 2021: 16 · 2020: 8 · 2019: 15 · 2018: 5
- FWCI
- 8.75
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Own your potential (DEAKIN) (submittedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- Diabetes UK (07/0003556)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- type 1 diabetes, impaired awareness of hypoglycemia, severe hypoglycemia, insulin pump therapy, multiple daily insulin injections, continuous glucose monitoring, self-monitoring of blood glucose, hypoglycemia education, hypoglycemia prevention, HbA1c, treatment satisfaction, fear of hypoglycemia, long-term follow-up
- MeSH terms
- Adult, Awareness, Blood Glucose, Diabetes Mellitus, Type 1, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Hypoglycemia, Injections, Insulin, Insulin Infusion Systems, Male, Middle Aged, Severity of Illness Index, Blood Glucose Self-Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.